BO
Schedule 13G filing
Bank of America Corp cut its INBX stake below 5%
Bank of America Corp reported owning 2.4% of Inhibrx Biosciences, Inc. (INBX) (357,318 shares) in a Schedule 13G filed Oct 28, 2026.
A 13G is a passive stake: the holder does not plan to push for changes.
- Disclosed
- Oct 28, 2026
- Source
- Schedule 13G
More INBX insider and Congress trades
From a public Schedule 13G, linked above. Not investment advice, and not a recommendation to buy or sell.